HHLR Advisors, Ltd. 13D and 13G filings for CELLULAR BIOMEDICINE GROUP, IN:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-06-24 4:38 pm Unchanged |
2020-06-24 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG |
HHLR Advisors, Ltd. | 235,214 1.200% |
0 (Unchanged) |
Filing |